The Latest in Hypertension

Clinical Endocrinology News

Top cardiology societies call for revamp of clinical trials

January 3, 2023

Clinical Endocrinology News

Black HFrEF patients get more empagliflozin benefit in EMPEROR analyses

December 21, 2022

Clinical Endocrinology News

High lipoprotein(a) levels plus hypertension add to CVD risk

December 20, 2022

Clinical Endocrinology News

Chlorthalidone, HCTZ equally effective in hypertension: DCP published

December 16, 2022

Hypertension

Clinical Endocrinology News

ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids

December 13, 2022

Clinical Endocrinology News

Gestational hypertension-diabetes combo signals CVD risk

December 2, 2022

New studies change beliefs about cardiovascular disease

November 30, 2022

Hypertension

Clinical Endocrinology News

Be aware, mindfulness training can lower systolic BP: MB-BP

November 18, 2022

Hypertension

Clinical Endocrinology News

Hypertension linked to risk of severe COVID

November 18, 2022

Clinical Endocrinology News

Baxdrostat slashes BP in resistant hypertension: BrigHTN

November 18, 2022

Hypertension

Clinical Endocrinology News

Sham-controlled renal denervation trial for hypertension is a near miss

November 15, 2022

Hypertension

Clinical Endocrinology News

Tirzepatide cuts BP during obesity treatment

November 15, 2022

Clinical Endocrinology News

Four-drug combo gets BP down in one step: QUARTET-USA

November 9, 2022

Hypertension

Clinical Endocrinology News

Study sheds new light on RAS inhibitors’ role for advanced CKD

November 7, 2022

Clinical Endocrinology News

Diuretic agents equal to prevent CV events in hypertension: DCP

November 5, 2022